Hao D, Han G, Sinjab A, Gomez-Bolanos LI, Lazcano R, Serrano A, Hernandez SD, Dai E, Cao X, Hu J, Dang M, Wang R, Chu Y, Song X, Zhang J, Parra ER, Wargo JA, Swisher SG , Cascone T, Sepesi B, Futreal AP, Li M, Dubinett SM, Fujimoto J, Solis Soto LM, Wistuba II, Stevenson CS, Spira A, Shalapour S, Kadara H, Wang L
Trauma recovery models begin with pretreatment assessment and an understanding of a victims current safety risk
Images/packaging/labels may vary due to manufacturing changes
Recalls & Warnings April 01, 2017 Maker of Prelief, Urinozinc Prostate Health Formula Warned for Manufacturing Violations On March 16, 2017 the FDA issued a warning letter to DSE Healthcare Solutions, LLC, following a facility inspection which found the company's products, including Prelief and Urinozinc Prostate Health Formula to be adulterated because they were prepared, packed, or held under
Applications: Obesity management, stubborn fat reduction, and metabolic syndrome
Single dose escalation studies with inhaled pol6014, a potent novel selective reversible inhibitor of human neutrophil elastase, in healthy volunteers and subjects with cystic fibrosis
